Neel Gandhi, MD VACS Leadership Meeting November 5, 2003

Slides:



Advertisements
Similar presentations
Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction Robert W. Yeh, MD MSc Massachusetts General Hospital Alan S. Go, MD Kaiser.
Advertisements

Cross Sectional Designs
 More than 2 million men and women have been deployed to Afghanistan and Iraq for Operations Enduring Freedom/Iraqi Freedom (OEF/OIF).  ~21% of men and.
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
Quality improvement for asthma care: The asthma care return-on-investment calculator Ginger Smith Carls, M.A., Thomson Healthcare (Medstat) State Healthcare.
Quality improvement for asthma care: The asthma care return-on-investment calculator Ginger Smith Carls, M.A., Thomson Healthcare (Medstat) State Healthcare.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November-December 2007.
1 Is Managed Care Superior to Traditional Fee-For-Service among HIV-Infected Beneficiaries of Medicaid? David Zingmond, MD, PhD UCLA Division of General.
Racial Differences in Quality of Care for Bipolar Disorder Center for Health Equity Research and Promotion Departments of Medicine and Psychiatry, University.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
Background There is uncertainty regarding the frequency, predictors, and outcomes of IRIS events Prior studies on IRIS have been limited to convenience.
Catherine Kober Margaret Johnson Martin Fisher Caroline Sabin On behalf of UK-CHIC BHIVA/BASHH Manchester 2010 Non-uptake of HAART among patients with.
HIV Mortality for Florida and the Six (EMAs) Eligible Metropolitan Areas Florida Department of Health HIV/AIDS & Hepatitis Program Death data as of 07/12/2012.
INTRODUCTION Evaluation of Outcomes in Patients Starting Antiretroviral Therapy During Hospitalization Leigh E. Efird, PharmD 1, Manish Patel, PharmD 1,
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
THE URBAN INSTITUTE Examining Long-Term Care Episodes and Care History for Medicare Beneficiaries: A Longitudinal Analysis of Elderly Individuals with.
Results Compliance with Breast Cancer Screening Guidelines in the HIV Clinic: A Quality Improvement Tool E. Patrozou M.D., E. Christaki M.D., L. Hicks.
HIV Mortality for Florida and the Six (EMAs) Eligible Metropolitan Areas Florida Department of Health HIV/AIDS Section Division of Disease Control and.
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
The Continuum of HIV Care Florida, 2014 The Continuum of HIV Care Florida, 2014 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2014, as of.
The Research Question What factors characterize the elite successes among HAART recipients in a NYC HIV care clinic?
Printed by A Follow-Up Study of Patterns of Service Use and Cost of Care for Discharged State Hospital Clients in Community-Based.
Is suicide predictable? Paul St John-Smith Short Courses in Psychiatry 15/10/2008.
Texas Pediatric Society Electronic Poster Contest
Effects of Case Management on Frequent
HIV Infection in Women in Our Community: The Continuum of Care
Mental and Behavioral Health Services
UNDERSTANDING THE MENTAL HEALTH SERVICE NEEDS OF DEPRESSED OLDER ADULTS: A STUDY OF AGE DIFFERENCES IN RECEIPT OF EVIDENCE BASED TEREATMENT FOR MAJOR.
Quality of Electronic Emergency Department Data: How Good Are They?
Disparities in Chronic Disease Management and Prevention: Findings from the 2006 National Healthcare Quality Report Authors: Anika Hines, MPH; Karen Ho,
“Its Different Now”: The Changing Landscape of HIV testing
Is High Placebo Response Really a Problem in Clinical Trials?
Age and Racial/Ethnic Disparities in the Diagnosis of Breast Cancer in an Urban Population Joanne K. Fagan PhD, Denise Fyffe, PhD, Nadine Jenkins, CTR,
Smartphone-Facilitated N-of-1 Trials for Improving Safety of Analgesic Regimens 1David Odineal, 2Rima Cabrera, 2Maria Marois, 2Sarah Benedetti, 2Peach.
Patient Registries and Health Outcomes in Diabetes: A Retrospective Study Nipa Shah, MD1; Fern Webb, PhD1; Liane Hannah, BSH1; Carmen Smotherman, MS2;
PCI related in-hospital mortality based on race and gender in the USA
2014 Texas Pediatric Society Electronic Poster Contest
Trends in Use of Pulmonary Rehabilitation Among Older Adults with Chronic Obstructive Pulmonary Disease Anita C. Mercado, Shawn P. Nishi, Wei Zhang, Yong-Fang.
Understanding Associations Between Serious Mental Illness and Hepatitis C among Veterans: A National Multivariate Analysis Seth Himelhoch, MD, MPH,1,2.
Women returning from Operation Iraqi Freedom/Operation Enduring Freedom: Comparison of Healthcare Utilization among Women & Men Veterans Mona Duggal MD.
Veterans with life-limiting illness: Baseline descriptors
Evidence of a Program's Effectiveness in Improving Colorectal Cancer Screening Rates in Federally Qualified Health Centers Robert L. Stephens, PhD, MPH1;
Blood eosinophils as a biomarker in alpha 1 antitrypsin deficiency
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
Total Hip Arthroplasty in HIV Positive Patients
Patient’s Perception of Physician’s Role in Spiritual Well-Being
How many sessions are Enough
53 Other Primary Diagnosis
autoimmune disorders in Iraq and Afghanistan Veterans
Perceived versus Actual Knowledge of Autism Spectrum Disorder
Chapter 7 The Hierarchy of Evidence
Insert Objective 1 Insert Objective 2 Insert Objective 3.
2016 Annual Data Report, Vol 2, ESRD, Ch 14
Marine Intercept Program: The Evolution of Caring Contacts
S1316 analysis details Garnet Anderson Katie Arnold
Subsequent Healthcare Utilization Associated With Early Physical Therapy for New Episodes of Low Back Pain in Older Adults Deven Karvelas, MD University.
ICD-10 Updates.
Cross Sectional Designs
2018 Annual Data Report Volume 1: Chronic Kidney Disease
The slides in this series are based on data compiled by NCHS from death certificates of US residents in the 50 states and the District of Columbia. The.
Peng-jun Lu, MD, PhD1; Mei-Chun Hung, MPH, PhD1,2 ; Alissa C
Chapter 12: End-of-life Care for Patients with ESRD:
AIDS Trends   For all slides in this series, the following notes apply:
Impact of Hepatitis C, HIV, or Both on Survival in Veterans in Care Before and After the Introduction of HAART (1996) SL Fultz, MD, MPH CH Chang, PhD AA.
Epidemiology of HIV Infection, through 2011.
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
Cancer is not a risk factor for bullous pemphigoid
Cervical Cancer Surveillance, Screening, and Treatment
Automated Monitoring of Injuries Due to Falls Using the BioSense System Achintya N. Dey, MA1, Jerome I Tokars, MD MPH1, Peter Hicks, MPH2, Matthew Miller,
Increased levels of alcohol use are associated with worse HIV care cascade outcomes among adults in Kenya and Uganda Sarah Puryear, MD, MPH University.
Presentation transcript:

Neel Gandhi, MD VACS Leadership Meeting November 5, 2003 Trends in Healthcare Utilization among HIV positive Veterans from 1998 - 2002: The VACS Virtual Cohort Data Neel Gandhi, MD VACS Leadership Meeting November 5, 2003

Introduction Throughout the 1990s, emphasis on shifting healthcare utilization from inpatient to outpatient setting Utilization at VA hospitals: Mean number of hospital days per patient-year declined by 40-60% from 1994 to 1998 Demonstrated among chronic medical and psychiatric illnesses (Ashton et al NEJM 2003) Good Afternoon. Throughout the 1990s, emphasis was placed on shifting healthcare utilization from the inpatient setting to the outpatient setting. Recent evidence demonstrates that this was true in the VA system as well. The mean number of hospital days per patient-year declined by 40 to 60% from years 1994 to 1998. This decline was demonstrated nationwide among patients with chronic medical or psychiatric illnesses

Utilization by HIV patients Decline in inpatient utilization well documented from 1996 to 1998 Attributed to introduction of Highly Active Antiretroviral Therapy (HAART) Unclear if this decline influenced by shift away from inpatient utilization in 1990s Few reports available regarding utilization among HIV patients after 1998 A decline in inpatient utilization has also been documented among HIV patients from 1996 to 1998. This decline is usually attributed to the introduction of Highly Active Antiretroviral Therapy. It is unclear, however, if this decline was also influenced by the shift away from inpatient utilization seen in other medical illnesses in 1990s Additionally, few reports are available in the literature describing utilization among HIV patients after 1998.

Objectives Among HIV-positive and HIV-negative patients at VA Medical Centers from 1998 to 2002, to examine: Trends in inpatient and outpatient healthcare utilization following initial presentation The effect of calendar year of presentation on patterns of utilization With this background, we proposed a study to examine, among HIV-positive and HIV-negative patients at VA medical Centers from 1998 to 2002, to examine: The trends of inpatient and outpatient healthcare utilization following initial presentation. And the effect of calendar year of presentation on patterns of utilization

Hypotheses Inpatient utilization would be greatest in year of presentation and gradually decline thereafter Outpatient utilization would increase to offset diminished inpatient utilization Changes in utilization among HIV group would not be subject to variation seen in non-HIV patients Our hypotheses when initiating this study, were that inpatient utilization would be greatest in the year of presentation and then gradually decline thereafter. Outpatient utilization, we expected, would increase to offset the diminished inpatient utilization Additionally, we believed that the changes in utilization seen among the HIV group, would not be subject to the variation seen historically in non-HIV patients

Methods Retrospective observational study Examining patterns of inpatient and outpatient utilization among HIV-positive patients and HIV-negative controls from fiscal years (FY) 1998 to 2002 Data abstracted from VA Austin Automation Center, uploaded from all 176 VA Medical Centers in US This is a retrospective observational study, examining the patterns of inpatient and outpatient utilization among HIV-positive patients and HIV-negative controls from fiscal years 1998 to 2002. The data were abstracted from the VA Austin Automation Center, which contains information uploaded from all 176 VA Medical Centers in the US.

Study Sample HIV patients Control patients Using ICD-9 and DRG codes, HIV patients identified in Austin database from FY 1991 to 2002 (N = 42,586) Eligible for study if first HIV code in FY 1998 to 2001 (N = 15,094) Control patients Lack an HIV-related ICD-9 or DRG code Matched 1:1 with HIV patients on age, sex, race and VISN Required to have active utilization in year that HIV match first identified with HIV code Using ICD-9 and DRG codes, 42-thousand-5-hundred-86 HIV patients have been identified in the Austin database from 1991 to 2002. These patients were eligible for our study if their first HIV code occurred between fiscal years 1998 and 2001. Control patients were drawn from the pool of patients who lacked an HIV-related ICD-9 or DRG code. Controls were matched on a one-to-one basis with HIV patients for age, sex, race and VISN. Control patients were required to have active utilization in the same fiscal year that their HIV match was first identified with an HIV diagnostic code

Definitions Utilization Year of presentation Inpatient: mean number of hospital days and admissions per patient-year Outpatient: mean number of outpatient visits to any VA clinic per patient-year Year of presentation HIV patients: Fiscal year in which patient is first identified as having HIV-related code Control patients: assigned year of presentation of HIV match Before I move on, I would like to mentioned a few definitions we used for this study: We defined utilization in the inpatient setting to be the mean number of hospital days and mean number of hospital admissions per patient year. Outpatient utilization was defined as the mean number of outpatient visits to any VA clinic per patient year. Another important definition to mention is Year of Presentation. We used the term “year of presentation” to refer to the fiscal year in which HIV patients were first identified with an HIV diagnostic code. Control patients were assigned the year of presentation of their HIV match.

Analysis Patients were grouped by HIV status and year of presentation Utilization data were aggregated based on the fiscal year in which they occurred Mean utilization per patient-year in year of presentation was compared to subsequent follow-up years For our analyses, patients were grouped based on HIV status and year of presentation. The utilization data were aggregated based on the fiscal year in which it occurred. Mean utilization per patient-year in the year of presentation was compared to utilization in subsequent follow-up years.

Outcomes Change in inpatient and outpatient utilization per patient-year as compared to baseline year of presentation Variation in mean utilization between groups with differing years of presentation The outcomes we were interested in, were the change in inpatient and outpatient utilization per patient-year, as compared to the baseline year of presentation. We were also interested the variation in mean utilization values seen between cohorts of differing calendar years of presentation.

Results: Demographics Demographics (Matched) HIV Group Control Group Age: Mean years (SD) 49.2 (12.6) Range 18 – 99 18 - 99 Sex: Male (%) 14,642 (97) 14,641 (97) Race: n (%) White 5436 (36.0) Black 5841 (38.7) Hispanic 1011 (6.7) Native American 31 (0.21) Asian 60 (0.40) Unknown 2716 (18.0) The results presented here are for baseline demographics of the study patients. Please remember that we matched patients in a 1-to-1 manner for these demographics. As expected the values in the two groups are nearly identical. The mean age of each group was 49.2 years with a standard deviation of 12.6 years. The groups were 97% male. The racial breakdown was 36% white, 39% black and 7% Hispanic. Less than 1% of each group was Native American or Asian. [Racial demographics were not known for 18% of the patients.]

Results: Year of Presentation Year of Presentation (Matched) HIV Group n (%) Control Group 1998 4781 (31.7) 1999 3996 (26.5) 2000 3394 (22.5) 2001 2924 (19.4) Total 15,094 (100) In this slide, we present a breakdown of the study groups based on the year in which patients presented with an HIV-related diagnostic code. Again, please recall that controls were matched to have utilization in that same year. 32% of patients presented in 1998, 27% 1999, 23% in 2000 and 19 % in 2001.

Prior Utilization Utilization prior to Year of Presentation HIV Group Control Group Year prior: n (%) 8,511 (54.6) 11,313 (74.9) Ever: n (%) 11,194 (74.2) 13,087 (86.8) # Years: Mean (SD) 4.3 (3.5) 5.1 (3.2) Before I present the outcomes of this study, I wanted to share a finding that surprised us. In this slide, I present data regarding utilization within the VA system prior to first appearance of an HIV diagnostic code. We found that roughly 55% of patients in the HIV group had utilization in the VA, the year prior to presenting with an HIV diagnostic code. In fact, 74% of HIV patients were seen in the VA at one time or another, prior to presenting with an HIV diagnostic code. The mean number of years between HIV patients’ first utilization in the VA system and their first HIV code was 4.3 years. These prior utilization numbers are comparable, although somewhat smaller than those seen with the control group.

Inpatient Utilization: Hospital Days With this slide, I begin my presentation of utilization data from this study. I will be presenting a series of graphs which will be similar in their make up. The data plotted will be for 4 groups based on the patients year of presentation. The y-axis will represent the mean utilization which we are analyzing; and the x-axis represents years of follow-up after presentation. The first graph of each pair will be for the HIV group and the second will present data from the control group. This slide shows Inpatient utilization as measured by mean # of hospital days per patient year. With these data we see that utilization is greatest in the year of presentation. It declines sharply in the second year and then more gradually in the remaining years of follow-up. Although utilization varies as patients progress in their course of follow-up, we note that the year in which they presented has little effect on their levels of utilization. [The lines for the individual cohorts overlap completely.]

Inpatient Utilization: Hospital Days This slide presents the same analysis, but for the Control Group. Here we note that inpatient utilization has a stable to slightly declining trend over the course of follow-up. In contrast to the HIV group, however, significant differences in utilization are present, based on year of presentation. It appears that the latter years of presentation have significantly lower rates of hospital days than the earlier years of presentation. Analyses were also performed for number of hospital admissions and ER visits per patient year. The utilization patterns mirrored those seen in these two graphs, and thus will not be shown.

Stratified Analysis for Prior Utilization In an effort to better understand the pattern of inpatient utilization just seen, we performed a stratified analysis for utilization in the year prior to presentation. Our goal was to determine whether differences in prior utilization were responsible for the large number of hospital days seen in the first year of the HIV group as compared to subsequent years. Here we find that regardless of whether the patients had utilization in the year prior to presentation, the utilization in the first year remains twice as great as that in subsequent years. Also noteworthy is that contrary to our initial belief, the patients who newly presented to the VA, had lesser utilization in the first year and for every year thereafter.

Stratified Analysis for Prior Utilization In the same stratified analysis of the Control group, the trend of utilization is similar to the non-stratified analysis. Again, patients with no prior utilization had fewer hospital days initially and throughout follow-up.

Outpatient Utilization: All Visits We now move onto Outpatient utilization. We analyzed all outpatient visits to VA clinics. In the HIV group, we find that the mean number of outpt visits declines gradually over the follow-up course, rather than increasing to compensate for the diminished inpatient utilization. Again, please note here that there is minimal variation based on year of presentation.

Outpatient Utilization: All Visits The outpatient utilization among the controls does increase, although gradually and only slightly. Here the variation based on year of presentation also appears to be minimal.

Limitations of Virtual Cohort These analyses are limited by absence of: CD4 counts and Viral Loads Date of HIV diagnosis Data regarding HAART use Addition of these data would allow further specificity of patterns of utilization among different clinical subgroups Our analyses are limited by the absence of CD4 counts and viral loads, the actual date of HIV diagnosis and data regarding HAART use The addition of these data would allow further specificity of patterns of utilization among different clinical subgroups

Conclusions Healthcare utilization among HIV veterans greatest in year of presentation Inpatient utilization two-fold greater in year of presentation compared to subsequent years Outpatient utilization diminishes modestly, rather than increasing to offset declines in inpatient utilization HIV utilization does not change significantly based on the year of presentation from 1998 to 2001 Differs from trend seen in non-HIV controls where inpatient utilization declined with each subsequent year of calendar time From this study, we conclude: First, Healthcare utilization among HIV veterans is greatest in year of presentation Inpatient utilization is two-fold greater in the year of presentation as compared to subsequent years Outpatient utilization diminishes modestly, rather than rising to offset declines in inpatient utilization HIV utilization does not change significantly based on the year of presentation This differs from trend seen in non-HIV controls where inpatient utilization declined with each subsequent year of calendar time

Conclusions cont’d Stratified Analyses based on utilization in the year prior to presentation reveal: Greater inpatient utilization in first year not influenced by prior utilization Patients new to VA have less inpatient utilization in first year, which persists throughout the course of follow-up Additionally, Stratified Analyses based on utilization in the year prior to presentation reveal: The pattern of greater inpatient utilization in the first year is not influenced by whether the patient had utilization prior to presentation. Patients new to the VA, however, have less utilization in the first year, which persists throughout the follow-up course.

Implications Year of presentation it may provide an opportunity for optimization of care Examination of practices in first year of HIV care (ie. coordination of care, patient education, screening and prophylaxis etc.) may reveal opportunities for improvement Characterization of patients with prior utilization to identify “at risk” population who may benefit from earlier diagnosis and intervention Further work necessary to determine why inpatient utilization lower among patients new to VA There are several implications of our study: First, since utilization is greatest in year of presentation, it may provide a good opportunity for optimization of care. Examination of practices in first year of HIV care (ie. coordination of care, patient education, screening and prophylaxis etc.) may reveal opportunities for improvement of care Second, considering that the majority of HIV patients had prior utilization, characterization of these patients may identify an at risk population of veterans who may benefit from earlier diagnosis and intervention. Third, further work is necessary to determine why inpatient utilization is lower for patients new to VA throughout their follow-up course.

Additional Slides

Number of Admissions

Number of Admissions cont’d

Urgent & Emergency Visits Here we present Urgent and emergency visits. The utilization pattern here is similar to the inpatient utilization.

Urgent & Emergency Visits cont’d It is true for the control group as well.

Medicine Clinic Visits

Medicine Clinic Visits cont’d

Baseline Marital Status HIV Group n (%) Control Group Married 3520 (23.3) 6638 (44.0) Never Married 5935 (39.3) 3731 (24.7) Divorced 4027 (26.7) 3458 (22.9) Separated 342 (2.27) 70 (0.46) Widowed 563 (3.73) 376 (2.49) Unknown 701 (4.65) 818 (5.42)